The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.

Clinical trial NCT00464737 · COMPLETED

Trial details

NCT number: NCT00464737
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibromyalgia Syndrome

Start date: 2007-03-01
Primary completion: 2008-11-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.